Using Light to Endow Stem-Cell-Derived Cardiomyocytes With Virtual I_K1 Conductances

Affiliations

Comment

Teun P de Boer. Biophys J. 2018.

. 2018 Dec 4;115(11):2079-2080.

doi: 10.1016/j.bpj.2018.10.019. Epub 2018 Oct 30.

¹ Department of Medical Physiology, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: t.p.deboer@umcutrecht.nl.

No abstract available

Comment on

Light-Activated Dynamic Clamp Using iPSC-Derived Cardiomyocytes.
Quach B, Krogh-Madsen T, Entcheva E, Christini DJ. Quach B, et al. Biophys J. 2018 Dec 4;115(11):2206-2217. doi: 10.1016/j.bpj.2018.10.018. Epub 2018 Oct 30. Biophys J. 2018. PMID: 30447994 Free PMC article.

1. Blinova K., Stohlman J., Strauss D.G. Comprehensive translational assessment of human-induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias. Toxicol. Sci. 2017;155:234–247. - PMC - PubMed
1. Ando H., Yoshinaga T., Sekino Y. A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes. J. Pharmacol. Toxicol. Methods. 2017;84:111–127. - PubMed
1. Goversen B., van der Heyden M.A.G., de Boer T.P. The immature electrophysiological phenotype of iPSC-CMs still hampers in vitro drug screening: special focus on IK1. Pharmacol. Ther. 2017;183:127–136. - PubMed
1. Jonsson M.K., Vos M.A., van Veen T.A. Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG. J. Mol. Cell. Cardiol. 2012;52:998–1008. - PubMed
1. Vaidyanathan R., Markandeya Y.S., Eckhardt L.L. IK1-enhanced human-induced pluripotent stem cell-derived cardiomyocytes: an improved cardiomyocyte model to investigate inherited arrhythmia syndromes. Am. J. Physiol. Heart Circ. Physiol. 2016;310:H1611–H1621. - PMC - PubMed